G

Glycominds

5 employees

Glycominds develops and commercializes autoimmune and chronic inflammatory disease management tools focused on multiple sclerosis.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Diagnostics
Inflammatory Bowel Disease (IBS) Diagnostics
Chron's Disease Diagnostics
Ulcerative Colitis Diagnostics

Date founded

2014

Funding rounds raised

Total raised

$1M

from 1 investors over 1 rounds

G

Glycominds raised $1M on January 1, 2005

Investors: BRM Group

FAQ